Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Heico
HEI
5
Nova Minerals
NVA
US Stock MarketDetailed Quotes
LSB LakeShore Biopharma
- 1.250
- +0.050+4.17%
Close May 1 16:00 ET
- 1.250
- 0.000-0.01%
Post 20:01 ET
23.85MMarket Cap-0.44P/E (TTM)
1.250High1.160Low4.33KVolume1.230Open1.200Pre Close5.22KTurnover0.12%Turnover RatioLossP/E (Static)19.08MShares11.20052wk High0.30P/B4.50MFloat Cap1.15052wk Low--Dividend TTM3.60MShs Float263.493Historical High--Div YieldTTM7.50%Amplitude1.150Historical Low1.206Avg Price1Lot Size
LakeShore Biopharma Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||
| Cash flow from continuing operating activities | -61.80%-295.23M | -5.14%-182.47M | 29.63%-173.55M | -246.61M |
| Net income from continuing operations | -197.96%-433.46M | -37.24%-145.48M | 44.74%-106M | ---191.83M |
| Operating gains losses | -20,715.19%-4.45M | -107.80%-21.36K | 1,001.39%273.98K | --24.88K |
| Depreciation and amortization | 14.98%42.19M | 17.76%36.69M | 11.64%31.15M | --27.91M |
| Deferred tax | -2,016.94%-21.73M | -77.04%1.13M | -71.71%4.94M | --17.45M |
| Other non cash items | 8.03%4.78M | 16.79%4.42M | 69.61%3.79M | --2.23M |
| Change In working capital | 50.63%-45.79M | 25.77%-92.75M | 33.08%-124.94M | ---186.68M |
| -Change in receivables | 108.41%13.9M | -139.32%-165.25M | 69.15%-69.05M | ---223.82M |
| -Change in inventory | -375.23%-86.26M | 79.71%-18.15M | -30.16%-89.46M | ---68.73M |
| -Change in prepaid assets | -158.82%-5.29M | -84.82%8.99M | -59.64%59.23M | --146.77M |
| -Change in payables and accrued expense | -56.23%40.56M | 536.95%92.66M | 45.11%-21.21M | ---38.63M |
| -Change in other current liabilities | -11.85%-5.09M | -19.86%-4.55M | -70.83%-3.8M | ---2.22M |
| -Change in other working capital | 44.06%-3.61M | -881.77%-6.45M | -1,382.67%-656.67K | ---44.29K |
| Cash from discontinued investing activities | ||||
| Operating cash flow | -61.80%-295.23M | -5.14%-182.47M | 29.63%-173.55M | ---246.61M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | 22.34%-44.25M | 80.94%-56.98M | -186.77%-298.92M | -104.24M |
| Net PPE purchase and sale | 16.02%-44.25M | 82.16%-52.69M | -183.30%-295.31M | ---104.24M |
| Net intangibles purchase and sale | --0 | -18.63%-4.29M | ---3.62M | --0 |
| Cash from discontinued investing activities | ||||
| Investing cash flow | 22.34%-44.25M | 80.94%-56.98M | -186.77%-298.92M | ---104.24M |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | -35.34%205.26M | -12.92%317.45M | -50.69%364.56M | 739.26M |
| Net issuance payments of debt | -178.25%-78.93M | -72.33%100.88M | 4,315.43%364.56M | --8.26M |
| Net common stock issuance | --284.2M | --0 | --0 | --1.59M |
| Net preferred stock issuance | ---- | ---- | ---- | --729.41M |
| Net other financing activities | ---- | --216.57M | ---- | ---- |
| Cash from discontinued financing activities | ||||
| Financing cash flow | -35.34%205.26M | -12.92%317.45M | -50.69%364.56M | --739.26M |
| Net cash flow | ||||
| Beginning cash position | 36.63%370.37M | -30.58%271.07M | 18,942.60%390.46M | --2.05M |
| Current changes in cash | -272.08%-134.22M | 172.28%78M | -127.78%-107.91M | --388.41M |
| Effect of exchange rate changes | -51.18%10.4M | 285.60%21.3M | -429,159.95%-11.48M | ---2.67K |
| End cash Position | -33.43%246.55M | 36.63%370.37M | -30.58%271.07M | --390.46M |
| Free cash flow | -41.73%-339.48M | 49.31%-239.52M | -34.42%-472.48M | ---351.49M |
| Currency Unit | CNY | CNY | CNY | CNY |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | -- | -- |
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now